Stocks / NASDAQ / NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

Our Opinion

NeuroSense Therapeutics Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for drug testing.

“Dr. Tracik’s presentation will include an overview of the design of NeuroSense’s upcoming Phase IIb ALS study, PARADIGM, and the therapeutic efficacy demonstrated in its Phase IIa trial and pre-clinical animal models (Zebrafish) to assess a synergistic combination therapy.” Read the following article

Company Description

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company’s preclinical pipeline includes StabiliC for the treatment of Parkinson’s disease; and CogniC for the treatment of Alzheimer’s disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

Company Website: